Potential effects of bisphosphonates on bone ultrastructure
- PMID: 19340500
- DOI: 10.1007/s00198-009-0865-6
Potential effects of bisphosphonates on bone ultrastructure
Similar articles
-
[Inhibitors of HMG-CoA reductase in prevention of osteoporosis and bone fractures. Similar mechanism of action of statins and bisphosphonates].Pol Arch Med Wewn. 2002 Jan;107(1):85-91. Pol Arch Med Wewn. 2002. PMID: 12046350 Review. Polish. No abstract available.
-
Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.Nutr Rev. 2006 Dec;64(12):509-17. doi: 10.1111/j.1753-4887.2006.tb00184.x. Nutr Rev. 2006. PMID: 17274493 Review.
-
The use of bisphosphonates in osteoporosis.Br J Clin Pract. 1994 Nov-Dec;48(6):323-6. Br J Clin Pract. 1994. PMID: 7848797 Review.
-
Clinical effects of bisphosphonates in involutional osteoporosis.J Bone Miner Res. 1993 Dec;8 Suppl 2:S597-606. doi: 10.1002/jbmr.5650081329. J Bone Miner Res. 1993. PMID: 8122531 Review.
-
Treatment of osteoporosis with bisphosphonates.Rheum Dis Clin North Am. 2001 Feb;27(1):197-214. doi: 10.1016/s0889-857x(05)70194-0. Rheum Dis Clin North Am. 2001. PMID: 11285996 Review.
Cited by
-
Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells.J Cell Mol Med. 2014 Jan;18(1):27-37. doi: 10.1111/jcmm.12154. Epub 2013 Oct 31. J Cell Mol Med. 2014. PMID: 24373581 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
